Tempest Therapeutics
Development-stage biotechnology company.
Launch date
Employees
Market cap
€33.2m
Enterprise valuation
€23m (Public information from Sep 2024)
Share price
$1.41 TPST
San Francisco California (HQ)
Authorizing premium user...